Wire · regulatory
Co-Diagnostics submits FDA 510(k) for respiratory test
◆ Sectors
Diagnostics
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 7 August 2026 · Fusion42 review
Co-Diagnostics has submitted a 510(k) premarket notification to the US FDA for regulatory clearance of a new respiratory test.
This Wire brief sits within Fusion42's coverage of Diagnostics, and 2 sources have reported it between 6 Aug 2026 and 7 Aug 2026.
◆ ◆ The Wire takeaway
The FDA submission opens a new US market for Co-Diagnostics' respiratory test and sets a regulatory precedent. You should prepare to accelerate US go-to-market plans or face competitors leveraging this approval as a barrier.
◆ Coverage
2 sources · first reported 6 Aug 2026 · latest 7 Aug 2026
◆ Related on Wire
◆ Topics
Diagnosticsfda510krespiratory-testregulatory-clearancediagnostics